The analysis on dynamic change and severity of IL-1 beta, TNF alpha, cox-2 detected by automatic enzyme immunoassay analyzer on patients with acute gout
10.3969/J.ISSN.1672-8270.2016.02.030
- VernacularTitle:全自动酶标仪检测严重程度不同的急性痛风患者的IL-1β、TNF-α、COX-2动态变化情况与结果分析
- Author:
Jing GOU
;
Wenju ZHANG
- Publication Type:Journal Article
- Keywords:
Acute gout;
IL-1β;
TNF-α;
COX-2;
Dynamic changes;
Automatic enzyme immunoassay analyzer
- From:
China Medical Equipment
2016;(2):95-98
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze dynamic change and severity of IL-1 beta, TNF alpha, COX-2 detected by automatic enzyme immunoassay analyzer on patients with acute gout.Methods: Ninety cases of acute gout patients selected according to the different degrees of severity, and were divided into three observed groups. Thirty health people were treated as the control group. IL-1β, TNF-α, COX-2 levels of dynamic change were recorded and compared within the four groups of patients.Results: The serum IL-1β, TNF-α, COX-2 levels in the 1st, 3rd, 7th, 10th day in the observation group 1 and group 2 in acute gout attacks were significantly higher than the control group; The serum levels of IL-1β, TNF-α, COX-2 levels in the 7th 10th day in observation group 1 in acute gout was significantly higher than observation group 2; The serum IL-1β, TNF-α,COX-2 levels in observation group 3 have not significant difference with control group 2; The serum IL-1β, TNF-α, COX-2 levels in observation group1,2,3 in acute gout attacks in the 14th days have not significant difference with control group.Conclusion: After analgesic drugs for the treatment of acute gout patients from 10 to 14 days, the inflammatory cytokines can be completely back to normal. The results provided important evidence for the introduction of analgesic drugs in patients with acute gout treatment.
